With the growing specialty drug pipeline that is contributing to nearly half of overall drug spend, we have been...

In our four-part series on specialty drug management, we have covered the importance of monitoring drugs before FDA...

Continuing our four-part series on specialty drug management, we first discussed the importance of monitoring drugs...

The pipeline of new drugs coming to market continues to be steady, with 50 novel drugs approved by the FDA in 2021.[1] ...

Prescription drug spend represented 13.7% of national health expenditures in 2018, totaling $500 billion, and is...

The pandemic continues to have a profound impact on healthcare and that includes the Centers for Medicare and Medicaid...

America has been in the throes of an opioid epidemic since the late ‘90s, with half a million people dying of opioid...

The pandemic had a dramatic impact on the American workforce with millions of workers becoming remote employees...

Even before the COVID-19 pandemic made its mark on history, large numbers of consumers were increasingly demanding...

Specialty medications continue to be a predominant topic in the healthcare industry, as more and more of these novel...